Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase 2 study of patients with chronic HCV infection.
Di Bisceglie AM, Janczweska-Kazek E, Habersetzer F, Mazur W, Stanciu C, Carreno V, Tanasescu C, Flisiak R, Romero-Gomez M, Fich A, Bataille V, Toh ML, Hennequi M, Zerr P, Honnet G, Inchauspé G, Agathon D, Limacher JM, Wedemeyer H. Gastroenterology. 2014 Jul;147(1):119-131
Ver en: http://www.gastrojournal.org/article/S0016-5085(14)00356-4/fulltext?referrer=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2F
